Concise review: induced pluripotent stem cells and lineage reprogramming: prospects for bone regeneration

Area of Science:

• Regenerative Medicine
• Stem Cell Biology
• Biotechnology

Background:

• High demand for bone tissue grafts in clinical settings due to osteodegenerative diseases (osteoporosis, osteoarthritis), congenital malformations, trauma, and tumor excisions.
• Existing bone tissue sources are often insufficient for therapeutic transplantation needs.
• Epigenetic reprogramming offers a pathway to generate patient-specific cells for tissue repair.

Purpose of the Study:

• To present induced pluripotent stem cells (iPSCs) and direct lineage reprogramming (LR) as key epigenetic reprogramming technologies.
• To outline the current research status of iPSCs and LR in the context of bone regeneration.
• To discuss potential strategies for implementing these cell-based therapies in clinical bone regeneration.

Main Methods:

• Review of current literature on induced pluripotent stem cells (iPSCs) derived from adult human skin cells.
• Exploration of direct lineage reprogramming (LR) techniques for in vivo tissue reconstitution.
• Analysis of research findings related to the application of iPSCs and LR in bone regeneration models.

Main Results:

• Induced pluripotent stem cells (iPSCs) can be generated from adult somatic cells, offering a source of pluripotent cells.
• Direct lineage reprogramming (LR) presents an alternative method for generating specific cell types, with potential for in vivo application.
• Both iPSCs and LR show promise for generating cells applicable to bone regeneration, though clinical translation requires further research.

Conclusions:

• iPSCs and LR are powerful epigenetic reprogramming tools with significant potential for advancing bone regeneration therapies.
• Further research and strategic implementation are necessary to translate these stem cell technologies into effective clinical treatments for bone defects and diseases.